Alnylam Pharmaceuticals has promoted Akshay Vaishnaw to the position of senior vice president of clinical research.
Vaishnaw previously served as Alnylam’s vice president of clinical research.
Pfizer has named Cathy Pachuk as senior director of delivery technology at its Research Technology Center, which focuses on, among other things, the company’s RNAi therapeutics efforts.
The company has also appointed C. Satishchandran as chief technology officer of the RTC.
Both Pachuk and Satishchandran were co-founders of Nucleonics, a now-defunct developer of expressed RNAi-based drugs. The company was shut down last year amid legal wrangling between the co-founders and senior management (see RNAi News, 11/6/2008).
Dicerna Pharmaceuticals has appointed Ronald Kahn to its scientific advisory board.
Kahn is currently a senior investigator at the Joslin Diabetes Center, where he heads the Joslin Section on Obesity and Hormone Action. He is also a professor of medicine at Harvard Medical School, according to Dicerna.